DAVE LINDORFF-There is an element of panic, since it’s becoming clear that this once-in-a-lifetime pandemic is looking potentially much worse than people up until now had been led to believe. In this so-called “epicenter,” for example, the number of “presumptive” cases of COVID-19 infection is currently 17 (since testing kits are scarce in the US, only six of the PA cases have been tested and they were all positive). That’s just about half the state’s total of 33 as of today. One MontCo resident has died so far, in a hospital in Philadelphia.
MEDICINE & SCIENCE
-
-
Scientists around the world have been racing to develop a vaccine and the first clinical trials could be held in China and the US within a month. But a number of cases, where people who had tested negative for the disease and were discharged from hospital only to give a positive result a few days later, have cast doubt on the process.
If it turns out that these patients had been reinfected by the same virus, then vaccines will not prove effective.
But the monkey experiment carried out by a team from the Chinese Academy of Medical Sciences may help dispel that fear. -
It’s not a crime if an epidemic broke out in hospitals with overworked staff. It is a crime to refuse an investigation. To try and distract attention from the epidemics inside the hospitals by demanding that effectively, martial law be declared in Lombardy and parts of Veneto, Lega’s dream of Padania. By relentlessly attacking Conte’s government every day while the tragedy unfolds in Lombardy.
-
Cancer Vaccine Candidate ImmuneFx Enters Human Study
16 minutes readFlorida scientists Michael and Patricia Lawman imagine a day when cancer could be treated with a single vaccination, with no debilitating side effects. And these scientists believe that day is coming sooner rather than later. This husband-and-wife Ph.D. team has developed a “cancer vaccine,” which is undergoing clinical trials at Tampa’s Moffitt Cancer Center, reported the Tampa Bay Times on August 12, 2019.
-
FW ENGDAHL—DARPA, the Pentagon R&D arm is spending millions on developing gene editing. In 2016 James Clapper, Obama Administration Director of National Intelligence added gene editing to the list of threats posed by “weapons of mass destruction and proliferation.” In July, 2017 the US Defense Advanced Research Projects Agency awarded $65 million in four-year contracts to seven teams of scientists to study gene-editing technologies. The commitment officially made DARPA the world’s largest government funder of “gene drive” research.